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RECENTLY, several investigators have
reported that specific cellular anti-tumour
reactivity can be detected by means of the
leucocyte migration inhibition (LMI) test
from capillary tubes (Cochran et al., 1973;
Kjaer,1975; McCoy et al., 1975) and also
by migration under agarose (Bergstrand
et al., 1974; Boddie et al., 1975; Tautz
et al., 1974). The purpose of the present
study was to compare the macrophage
electrophoretic mobility (MEM) test intro-
duced by Caspary and Field (1970) with
LMI under agarose (Clausen, 1971) using
allogeneic KCI extracts of tumours and
normal tissues, carcinoembryonic antigen
(CEA) and human encephalitogenic pro-
tein (HEP).
Twenty-one patients who were expected
to undergo biopsy or surgery, were selected
to give blood before any definite diagnosis
and therapy. Fifteen patients were divided
into the following groups: 4 with broncho-
genic carcinomas, 3 with gastric carcino-
mas, 3 with colonic carcinomas and 5 with
renal carcinomas (hypernephromas). No
tumour patient was in a terminal stage
with haematogenic metastases. In 6
patients suspected at first of having a
tumour, the diagnoses could not be
confirmed. The diagnosis in these cases
were: volvolus (1), chronic gastritis with
strictures (2), pyloric ulcer (1), renal cyst
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(1) and mastopathia cystica fibrosa (1).
In addition, 6 healthy blood donors
were examined.
Human encephalitogenic protein (HEP)
was prepared from human brain (Caspary
and Field, 1965). Carcinoembryonic anti-
gen (CEA) was obtained from liver
metastases of a colonic adenocarcinoma
(Grossmann et al., 1975).
Extracts in 3M KCI from surgically
removed carcinomas (TAA) andfrom nor-
mal tissues (NTA) were prepared accord-
ing to the method of Meltzer et al. (1971)
with slight modifications described by
Muller et al. (1975). They were taken from
single carcinomas, except for bronchogenic
carcinoma extract, which was pooled
from an oat-cell carcinoma, an adeno-
carcinoma and a squamous-cell carcinoma.
Extracts were lyophilized and dissolved
immediately before use.
Leucocytes were obtained from buffy
coat of heparinized blood by sedimenta-
tion with dextran. They were washed x 3
and resuspended in Eagle's minimal essen-
tial medium (Institut fur Nahrmedizin
und Immunpraparate, Berlin GDR) con-
taining 10% human serum (pooled from
AB donors) 66 u/ml penicillin and 66 jig/
ml streptomycin.
Cell suspension in 40,u1 (2.5 x 105
leucocytes/,ul) were added to separate
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test tubes ("U" microtitre plates may be
used), mixed with 10 ,ul of the antigen
solution or a PBS control, and incubate
for 1 h at 37°C. Antigen protein was
used at the rate of 100 Hg per leucocyte
sample.
Fresh agarose plates (0.90%) were pre-
pared by mixing a doubly concentrated
agarose solution at 48°C with the same
quantity of medium with 10% human
serum, and pouring the mixture on to
glass plates placed in rectangular trays.
Thirty holes were cut in each agarose
plate with a 2-5mm hypodermic needle,
using a stencil. After that, the contents of
each tube were resuspended and 10 [LI
were put into the wells of agarose plates
in triplicate with a triplicate control on
each plate. Plates were then placed in
moist chambers for 18 h at 37°C. Agarose
plates were fixed with methanol for 30 min
followed by 35% formalin for 30 min.
Thenthe agaroselayer wasgentlyremoved,
glass plates were air-dried and migration
areas were analysed by means of a
(9 x 12) cm slide projector. The migration
index (MI) was calculated as the ratio be-
tween average areas of cultures containing
antigen (TAA) andcontrol cultures on each
plate. Results were analysed by Student's
t test to establish P values. In preliminary
studies, the mean value ± s.d. of the MIs
in 6 healthy blood donors and in 6 non-
tumour patients was 0 83-1-20 at 100 [Lg
TAA. MI values of 0-80 or less and above
1 20 were considered significant. Values
from 0 79 to 0-80 were taken as borderline.
The method for the MEM test has been
described in detail elsewhere (Irmscher
et al., 1975; Muller et al., 1975). In brief,
human lymphocytes were prepared from
defibrinated blood (Hughes and Caspary,
1970). After washing, the lymphocytes
were resuspended in Eagle's Minimal
Essential Medium distributed to test tubes
(106 lymphocytes/2-5 ml) and incubated
with 100 ,ug protein of several KCI
extracts (0.1 ml) for at least 90 min at
37°C. Then supernatants were removed
and mixed with irradiated macrophage
suspension (107 cells in 0-5 ml). The
electrophoretic mobility of 25-40 cells
per sample was measured simultaneously
in 2 cytopherometers (Opton, Oberko-
chem, FRG) with a maximum oftolerated
time difference of 20%. The times mea-
sured for single cells of one sample were
averaged and percentage of slowing was
calculated as
mean time of test mixture x 100
mean time of all samples without slowing
The results were calculated with a com-
puterized t-test programme, and slowings
were considered to be significant if P
was < 0 05. On an experimental basis the
slowings were interpreted as follows:
<500 =_ no effect; 5-100 weak result,
estimated ultimately by calculation of sig-
nificance, >1000= strong positive result.
Blood samples from 21 patients and
6 healthy blood donors were investigated
with the same antigens simultaneously in
LMI and MEM tests (Figs. 1-4). In 15/21
cases, malignant tumours were confirmed
by histological examination. Fig. 1 shows
the 15 cases tested with tumour extracts
of the same individual tumour type. Ten
cases could be found to agree in positive
reactions. Three cases of renal carcinoma
reacted only in the MEM test with the
kidney carcinoma extract, but in the
LMI, 2 of these reacted with the corre-
sponding normal tissue antigens (NTA).
One case ofgastric carcinoma only reacted
in the LMI with the gastric carcinoma
antigen which was common to both test
systems. Another gastric carcinoma
extract, used only in the MEM test, and
a colonic carcinoma extract, gave full
MEM reaction in this case. One case of
colonic carcinoma failed to react with
colon cancer extract in both systems.
KCI extracts expected to be negative are
compared in Figs. 2 and 3, but only cases
showing lack of correspondence were
marked. Only 2 cross-reactions with >10%
macrophage slowing could be seen in the
MEM test (Fig. 2, 3) both in cases of
gastrointestinal cancer. In LMI the num-
ber of cross-reactions with NTA and non-
corresponding TAA was greater than in
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MEM, but 7/9 cross-reacting NTA extracts
had the same tissue type as the tumour.
CEA was tested in both gastrointestinal
and non-gastrointestinal carcinomas (Fig.
4). Five out of 6 gastrointestinal carci-
nomas were recognized by the MEM test
and 4/6 by LMI. One case of a gastric
carcinoma arising from a gastric ulcer
FIGS. 1-3.-LMI compared to MEM. React-
ivity against TAA and NTA in 15 cases of
carcinoma tested in LMI and MEM tests.
Abscissa indicates the MI difference from
1-00 (x 100) recording stimulation as well
as inhibition; the ordinate indicates the
percentage of macrophage mnobility inhibi-
tion.
0 0., colonic; A A, gastric; U Fii, renal;
W v7 hrnlnrnn /P1Rh1n- TA A Wbito ~ '~ ~ '
NTA) x ,mammary TAA. Hatched regi,
include all other antigens tested.
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Fig. 3.-Results with allogeneic NTA (in LMI
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type as the tumour in that case). (Cross-
reactivity).
~ons gave negative results in both tests. One
patient with a kidney carcinoma showed
an MI value with CEA which could not be
correlated with the MEM test. A further
positive LMI with CEA was caused by a
carcinoma of the gallbladder. Common
examinations with REP in 6 tumour
patients showed significant reduction of
macrophage mobility in the MEM test,
but neither in these cases nor in additional
cases examined only in LMI could migra-
tion inhibition be observed. Six patients
suspected of tumour before biopsy and
6 healthy blood donors showed no
1Ml migration effect with any antigen tested,
L MI with the exception of one borderline
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reaction in a case of clinically suspected
mammary carcinoma, which showed an
MI of 0 80 with kidney carcinoma extract.
In comparison with the Clausen assay,
the MEM test consumes more time and
needs specialized equipment and experi-
enced investigators, but could be shown to
be a highly specific test system (Irmscher
et al., 1975; Miiller et al., 1975; Seyfarth
et al., 1976). The Clausen assay is very
suitable for clinical studies detecting anti-
tumour reactivity, because of the simple
cell-separation procedure, the inexpensive
fitting-out and the quick evaluation and
preserving method. A further advantage
could be provided by using large culture
plates, thus giving the same prere-
quisites to a great number of different
test samples. Bergstrand et al. (1974)
performed an analysis on the methodo-
logical variability of LMI under agarose.
They showed that technical errors in the
method can be reduced to a reasonable
level, making it possible to observe
relatively small specific effects of antigen.
In our study, 14/15 carcinomas could
be detected and localized using the cor-
responding cancer extract, and partly by
reactions with allogeneic NTA.
By use ofa battery ofantigenic prepara-
tions, some tumours which fail to be
detected by a single antigen can be indi-
cated in a comparison of different TAA
and NTA preparations in different test
systems. Previously, HEP was reported
to be an antigen which caused reaction
in a great number of tumour patients
(Irmscher et al., 1975; Meyer-Rienecker
et al., 1974; Mtiller et al., 1975). We
could not confirm this finding in LMI
performed simultaneously with positive
MEM test. Bergstrand et al. (1974) also
described negative results with HEP in
7/9 carcinomas (LMI).
Using KCI extracts for antigens, the
MEM test seems to be superior to the
LMI in respect of its specificity, but LMI
can be helpful in laboratories not possess-
ing the equipment necessary for the MEM
technique. Because of the considerable
number of false-negative results pre-
viously reported, a great number of
repeatedly proved and well-defined anti-
gens in few standard concentration steps
must be used to avoid false-negative
results. Then LMI shows sufficient sensi-
tivity, but one needs a very simple
technique, for instance Clausen's, to
perform the great number of single tests
needed in each "checking programme".
The authors thank Dr Gold, Montreal, for testing
our CEA substances.
We wTish to thank also Institut fuir Impfstoffe,
Dessau, GDR, for help and support in preparing
the KCI extracts.
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